Stockscreener 앱 받기
42.76
12.02%
4.7524
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker shares rise 4% on first quarter earnings beat By Investing.com - Investing.com Canada
Bruker: Q1 Earnings Snapshot - KVUE
Bruker (NASDAQ: BRKR) Q1 2026 revenue rises 2.7% as FY26 outlook held - Stock Titan
Bruker sales rose, but earnings fell as it kept 2026 forecast - Stock Titan
MSN Money - MSN
Bruker earnings on deck as first quarter results loom Wednesday By Investing.com - Investing.com Canada
Bruker earnings on deck as first quarter results loom Wednesday - Investing.com
Related_a1otxm - MSN
Earnings Preview: Bruker Corp to Report Financial Results Pre-market on May 06 - Moomoo
Bruker Launches High-Throughput Molecular Diagnostic System for Infectious Diseases in Europe - Clinical Lab Products
Bruker Corp (BRKR) Shares Fall 5.4% -- What GF Score of 81 Tells Investors - GuruFocus
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Bruker (BRKR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker enhances MALDI and IR Biotyper for infection control - SelectScience
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp | 8-K: Current report - Moomoo
Bruker (NASDAQ: BRKR) sets $3.9844 dividend on 6.375% preferred - Stock Titan
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 135,470 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Hits Day Low at $34.88 Amid Price Pressure - Markets Mojo
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Bruker acquires Austria based biocrates - MSN
Peregrine Capital Management LLC Raises Holdings in Bruker Corporation $BRKR - MarketBeat
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Bruker Corp (BRKR) Stock Down 8.7% -- Now Undervalued? GF Score: 81/100 - GuruFocus
Bruker (NASDAQ:BRKR) Stock Price Down 8.7%Time to Sell? - MarketBeat
Trending Industry Today: Bruker Corp Leads Losses In Room-Temp Superconductors Stocks - Moomoo
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Is Bruker (BRKR) Fairly Priced After Recent Short Term Share Price Rebound? - Yahoo Finance
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - 富途牛牛
Bruker Corp stock (US1167941087): Is its scientific instruments edge strong enough for steady growth - AD HOC NEWS
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer M - GuruFocus
Bruker (BRKR) Unveils Innovations for Cancer Research at Upcomin - GuruFocus
A Look at Bruker Corp (BRKR) After 4.5% Gain -- GF Value $71.47 vs Price $40.70 - GuruFocus
Bruker unveils spatial biology workflows, opens PaintScape pre-orders By Investing.com - Investing.com Canada
Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker expands microbiology portfolio with new testing tools By Investing.com - Investing.com South Africa
0.76%
0.72%
자본화:
|
볼륨(24시간):